Intraocular Position of Secondary Iris-Fixated IOLs in Aphakic Eyes
This study has been completed.
Information provided by (Responsible Party):
Michael Koss, Johann Wolfgang Goethe University Hospitals
First received: October 15, 2008
Last updated: September 26, 2012
Last verified: September 2012
The purpose of this study is to evaluate the intraocular stability and safety of secondary iris-fixated IOLs in aphakic patients.
||Observational Model: Case-Only
Time Perspective: Retrospective
||Intraocular Architecture of Secondary Implanted Anterior Chamber Iris-Fixated Lenses in Aphakic Eyes Evaluated With Anterior Segment Optical Coherence Tomography
Primary Outcome Measures:
- Intraocular IOL position [ Time Frame: 12-35 months postoperatively ] [ Designated as safety issue: No ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||June 2008 (Final data collection date for primary outcome measure)
18 eyes of 16 patients received secondary anteriorly iris-fixated intraocular lenses (IOLs) to correct for aphakia without capsular support, partly combined with anterior or complete pars plana vitrectomy. Primary outcome measurements included visual acuity (6m Snellen charts), central endothelium cell count (cECC) and postoperative intraocular position of the IOL assessed with anterior segment optical coherence tomography (OCT).
|Ages Eligible for Study:
||16 Years to 84 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Patients with long standing Aphakia and eligibility for secondary IOL implantantion were retrospectively examined
- Patients with aphakia due to complicated cataract surgery, weakness in lens support (capsula, zonulae) Marfans´s syndrome
- Aphakia due to preexisting corneal, retinal o uveal disease, low endothelial cell count
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00773266
|Zentrum für Augenheilkunde
|Frankfurt, Hessen, Germany, 60590 |
Johann Wolfgang Goethe University Hospitals
No publications provided
||Michael Koss, PI, Johann Wolfgang Goethe University Hospitals
History of Changes
|Other Study ID Numbers:
|Study First Received:
||October 15, 2008
||September 26, 2012
||Germany: Ethics Commission
Keywords provided by Johann Wolfgang Goethe University Hospitals:
Anterior Segment OCT
Aphakia - secondary iris-fixated IOL position
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on April 23, 2015